Company Profiles

driven by the PitchBook Platform

Ankasa Regenerative Therapeutics

Ankasa Regenerative Therapeutics
PRIVATE STATUS
Series A LATEST DEAL TYPE
$9.5M LATEST DEAL AMOUNT
$9.5M TOTAL AMOUNT RAISED
3 INVESTORS
Description

Developer of bio-pharmaceutical strategies designed to improve tissue healing. The company's bio-pharmaceutical strategies utilizes proprietary formulations of a potent WNT stem cell activator that accelerates tissue healing, enabling patients to avail demonstrated superiority in terms of bone reformation over existing standards of care in various preclinical models.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Primary Office
11099 North Torrey Pines Road
Suite 290
San Diego, CA 92037
United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ankasa Regenerative Therapeutics’s full profile, request a free trial.

Ankasa Regenerative Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 30-Jul-2015 $9.5M $9.5M Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Ankasa Regenerative Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Avalon Ventures Venture Capital Minority 000 0000 000000 0
Correlation Ventures Venture Capital Minority 000 0000 000000 0
JLABS Accelerator/Incubator 000 0000 000000 0

Ankasa Regenerative Therapeutics Executive Team (2)

Name Title Board
Seat
Contact
Info
Sanford Madigan Ph.D Chief Executive Officer
Scott Burkette Co-Founder